Heart failure & cardiomyopathies
Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis
Main finding · HF hospitalizationsResult — go to the resultHazard ratio 0.22Authors' conclusion
Based on the results, we suggest that remote monitoring of pulmonary artery pressure with the CardioMEMS HF System represents a midterm and long-term efficient strategy in a healthcare setting in Southern Europe.
Study context
- Population
- Heart failure (HF) patients implanted with a pulmonary artery pressure sensor at an HF clinic in Spain; reduced and preserved LVEF, 67.4% NYHA class III
- Participants
- 43 patients
- Comparison
- CardioMEMS HF System vs usual management
- Outcome
- HF hospitalizations
- Follow-up
- 1 year
Methodological detailssingle-centre before–after study, consecutive patients
- Single-centre before–after study
- Consecutive patients
Main finding
As reported in the abstract
Hazard ratio
0.22
P = 0.001
By group
Further findings
Cost–benefit · end of first year
- Usual management outperformed the CardioMEMS HF System
Cost–benefit · end of second year
- CardioMEMS estimated to reduce costs vs usual management (net benefits)
- €346
Original publication
Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis. ESC Heart Fail. Published 18 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →